News: News
12 May 2026
Three Years, Twelve Thousand Lives Reached: Dexa Group Expands Access to Free Health Screenings
Bandung — Dexa Group continues to expand public access to early detection and health education through its Cek Segitiga: Free Health Screening program. Now entering its third year, this initiative, organized through Dharma Dexa, has reached more than 12,000 people across various cities in Indonesia. During its latest event at…
8 May 2026
Halal Pharmaceutical Products Strengthen Indonesia’s National Healthcare Ecosystem
Tangerang — Strengthening halal pharmaceutical products has become a shared priority among regulators, industry players, and healthcare providers in Indonesia. Ensuring the halal status of medicines is increasingly seen as essential to delivering safe, high-quality healthcare while providing peace of mind for the public. Indonesia’s Vice Minister of Health, Prof.…
29 April 2026
Ahead of the 2026 Deadline: Halal by Design, Dexa’s Commitment from the Earliest Stages of Research
Jakarta - In less than six months, Indonesia’s pharmaceutical industry landscape is set to change significantly. Starting October 17, 2026, all natural medicines, quasi-drugs, and health supplements distributed across the country must be halal-certified. For Indonesia’s 246 million Muslims—representing 87.08% of the national population, according to the Directorate General of…
20 April 2026
Thousands of People in Solo Join Free Health Check Program
Solo – More than 1,000 people in Solo took part in the Cek Segitiga, free health check program initiated by Dharma Dexa PT Dexa Medica at Manahan Stadium on Sunday, April 19, 2026. The strong turnout reflects growing public awareness of the importance of early detection through blood pressure, blood…
14 April 2026
High Public Enthusiasm in Bogor, Free Health Screening Draws Strong Interest
Bogor - A free health screening program received an enthusiastic response from residents of Bogor and surrounding areas. Results from the screening, which involved hundreds of participants, revealed that 7 out of 10 people—or 73.8%—are at risk of chronic diseases such as hypertension, diabetes, and high cholesterol. These findings highlight…
8 April 2026
Advancing Toward Mandatory Halal 2026 Through Stronger Collaboration
Halal is not merely an obligation—it is the foundation of trust. From there, quality is reflected and built. As Indonesia approaches the mandatory halal implementation in 2026, Dexa Group is taking concrete steps to ensure every process remains compliant while embodying trusted quality. In line with this commitment, Dexa Group’s…
16 March 2026
Ramadan 2026: “Boost Immunity, Strengthen Faith” Movement Supports Recovery in Aceh Tamiang
Ramadan 2026 serves as a meaningful moment to strengthen social solidarity while reinforcing care for public health. Through the campaign “Boost Immunity, Strengthen Faith,” organized in collaboration with Dompet Dhuafa, the public is encouraged to participate in a collective giving movement to support communities affected by disasters in Aceh, particularly…
20 February 2026
From Quality to Public Trust
In the healthcare industry, public trust is not built overnight. It grows through consistent quality assurance, adherence to standards, and contributions that are tangibly felt by society. As demands for transparency continue to rise, healthcare companies are expected not only to deliver good products, but also to establish accurate and…
3 February 2026
Dexa Medica Receives the 2026 BPOM Achievement Award as Indonesia’s Leading Phytopharmaceutical Company
Dexa Medica has once again affirmed its role as a pioneer in Indonesia’s pharmaceutical industry through an award presented by the National Agency of Drug and Food Control (BPOM) of the Republic of Indonesia. The BPOM Achievement Award 2026 in the category of Pioneer with the Highest Number of Phytopharmaceutical…
30 December 2025
Right to Win Through Visionary Leadership: Dexa Group Wins the Indonesia CEO Excellence Award 2025
Dexa Group has once again achieved a strategic milestone by receiving the Indonesia CEO Excellence Award 2025, organized by WartaEkonomi.co.id Research and Consulting. This award recognizes visionary leadership that consistently drives business sustainability while strengthening the pharmaceutical sector’s contribution to national health resilience. The award was presented by Muhamad Ihsan,…
